• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
Relative Bioavailability of Oxcarbazepine Tablets in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2004, (3): 50-53.
Citation: Relative Bioavailability of Oxcarbazepine Tablets in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2004, (3): 50-53.

Relative Bioavailability of Oxcarbazepine Tablets in Healthy Volunteers

More Information
  • Related Articles

    [1]REN Weijie, CEN Lifang, ZOU Yi. Research progress of Bruton's tyrosine kinase (BTK) inhibitors in the treatment of inflammatory and immune-mediated diseases[J]. Journal of China Pharmaceutical University, 2024, 55(1): 63-72. DOI: 10.11665/j.issn.1000-5048.2023121103
    [2]WANG Chen, ZHANG Zhengping, LI Yinchun. Development strategy and clinical research progress of universal chimeric antigen receptor T-cell drugs[J]. Journal of China Pharmaceutical University, 2023, 54(2): 141-149. DOI: 10.11665/j.issn.1000-5048.20211125001
    [3]GAO Jing, MI Xue, ZHOU Qi, ZHOU Jun. Research progress of N6-methyladenine demethylase inhibitors[J]. Journal of China Pharmaceutical University, 2022, 53(6): 663-673. DOI: 10.11665/j.issn.1000-5048.20220604
    [4]ZHU Zhixi, ZHANG Jielin, CHEN Yijun. Recent advances in research on chelators as metallo-β-lactamase inhibitors[J]. Journal of China Pharmaceutical University, 2022, 53(4): 410-422. DOI: 10.11665/j.issn.1000-5048.20220404
    [5]YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615
    [6]LIU Xiaoqing, LIANG Shuang, LIU Yongjun, ZHANG Na. Progress of research on inhibition strategy of bromodomain-containing protein 4 and its application in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(3): 270-278. DOI: 10.11665/j.issn.1000-5048.20210302
    [7]WEI Yuanyuan, YANG Fan, TANG Jie, YU Lifang. Advances in the research of anti-tuberculosis drugs[J]. Journal of China Pharmaceutical University, 2020, 51(2): 231-239. DOI: 10.11665/j.issn.1000-5048.20200215
    [8]YUAN Zhong, CHEN Zhuo, LI Qianbin, HU Gaoyun. Advances in research of protein tyrosine phosphatase 1B and its inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(1): 1-9. DOI: 10.11665/j.issn.1000-5048.20180101
    [9]GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
    [10]YAO Aihong, CHANG Yujie, JIANG Cheng, SUN Haiying. Research progress of Polo-like kinase 1 inhibitors targeting Polo-box domain[J]. Journal of China Pharmaceutical University, 2016, 47(1): 1-8. DOI: 10.11665/j.issn.1000-5048.20160101

Catalog

    Article views (1194) PDF downloads (963) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return